Matthew MaddenPartnerMcDermott Will & Emery Websitewww.mwe.comOrganization ProfileFull ProfileBlogwww.mwe.com/insights/ConnectEmailTwitterLinkedIn+1 312 984 7700 Professional Biography Matthew (Matt) Madden is a first-chair trial lawyer who has tried more than 25 federal criminal trials. The former chief of the Criminal Division of the US Attorney’s Office (USAO) in Chicago, he leverages his more than 15 years with the US Department of Justice (DOJ) when handling white-collar and regulatory enforcement matters, internal investigations, compliance matters and complex civil litigation for clients. More Legal and Business Bylines From Matthew Madden DOJ Doubles Down on Corporate Enforcement with New Whistleblower Program - (Posted On Friday, March 15, 2024) Current Legal Analysis MEMA Original Equipment Suppliers Annual Conference – Outlook Panel’s Economic and Growth Forecasts for the Automotive Industry by: Aline Silva , Steven H. Hilfinger You See Health, Whistleblower Saw Fraud: Uncovering a $23 Million Healthcare Fraud Scheme by: Tycko & Zavareei Whistleblower Practice Group SCOTUS Takes Up Reverse Discrimination Framework Under Title VII by: Jennifer B. Rubin , Talia R. Weseley Wawrzenski v. United Airlines, Inc.: Key Takeaways for Employers Navigating Workplace Policies by: Morgan Forsey , Marissa Rael Cyber Resilience Act Published in the Official Journal of the EU by: Hunton Andrews Kurth’s Privacy and Cybersecurity Employers Are Extra Grateful This Thanksgiving After Federal Court Sets Aside DOL’s Salary Threshold Increase by: Theresa A. Topping Upcoming Events Dec 10 2024 Legal AI Week 2024 Nov 21 2024 CC&Rs and Easements for Mixed-Use Projects: Best Practices for Developers Nov 21 2024 AI Patent Eligibility: Processing the USPTO's New Guidance Nov 21 2024 Update of 2024 California Employment Law Cases Nov 25 2024 2024 Election: Impact on the Health Care Legal and Policy Landscape Webinar Dec 4 2024 GLP-1 Drugs: What's Next after FDA's Resolution of Drug Shortages Dec 4 2024 TSCA 30/30 - December 4, 2024 Dec 4 2024 REACH 30/30 - 04 December 2024 Print
